Meanwhile, as an inhibitor of IL-6/gp130, raloxifene could ameliorate myocardial remodeling in TAC mice, attenuate HF, and partially maintain cardiac function at the late stage (Huo et al., 2021). This evidence concerns the gene IL6 and hydrops fetalis.